Clifford G. Robinson, MD | Department ...

Dr. Clifford G. Robinson

Claim this profile

Washington University School of Medicine

Studies Lung Cancer
Studies Small Cell Lung Cancer
12 reported clinical trials
29 drugs studied

Area of expertise

1

Lung Cancer

Clifford G. Robinson has run 7 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Small Cell Lung Cancer

Clifford G. Robinson has run 3 trials for Small Cell Lung Cancer. Some of their research focus areas include:

Stage I
Stage II
Stage IV

Affiliated Hospitals

Image of trial facility.

Washington University School Of Medicine

Image of trial facility.

Siteman Cancer Center At West County Hospital

Clinical Trials Clifford G. Robinson is currently running

Image of trial facility.

Proton Radiotherapy

for Palliative Cancer Care

Spatially fractionated radiotherapy (SFRT or GRID) addresses some limitations of traditional stereotactic body radiation therapy by relying on beam collimation to create high-dose "peaks" and intervening low-dose "valleys" throughout the target volume. Standard palliative radiotherapy regimens provide limited durability of response, and there are challenges with delivery to large tumors or in previously irradiated fields. In this study, Proton GRID radiotherapy will be used to deliver three-fraction palliative radiotherapy to patients with tumors needing palliative radiation. The safety and efficacy of this approach will be assessed. It is hypothesized that GRID is highly effective, immunogenic, and associated with low rates of toxicity.

Recruiting

1 award

N/A

Image of trial facility.

MRI Monitoring vs. Preventive Brain Radiation

for Small Cell Lung Cancer

This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.

Recruiting

2 awards

Phase 3

22 criteria

More about Clifford G. Robinson

Clinical Trial Related

3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Clifford G. Robinson has experience with

  • Docetaxel
  • Gemcitabine
  • Erlotinib Hydrochloride
  • Local Consolidation Therapy
  • Pemetrexed Disodium
  • Prophylactic Cranial Irradiation

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Clifford G. Robinson specialize in?

Is Clifford G. Robinson currently recruiting for clinical trials?

Are there any treatments that Clifford G. Robinson has studied deeply?

What is the best way to schedule an appointment with Clifford G. Robinson?

What is the office address of Clifford G. Robinson?

Is there any support for travel costs?